117. Syringomyelia Clinical trials / Disease details
Clinical trials : 3 / Drugs : 5 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000039678 | 2021-02-01 | 2020-11-05 | Evaluation of Posterior Fossa Decompression (PFD) without or with Cerebellar Tonsil Thermocoagulation (PFDCT) for Arnold-Chiari Malformation Type I with Syringomyelia: a ramdomised controlled trial | Evaluation of Posterior Fossa Decompression (PFD) without or with Cerebellar Tonsil Thermocoagulation (PFDCT) for Arnold-Chiari Malformation Type I with Syringomyelia: a ramdomised controlled trial | Arnold-Chiari Malformation Type I with Syringomyelia | A Group:Posterior Fossa Decompression;B Group:Posterior Fossa Decompression (PFD) with Cerebellar tonsil Thermocoagulation (PFDCT); | Fujian Medical University Union Hospital | NULL | Recruiting | 18 | 65 | Both | A Group:70;B Group:70; | China |